// App-Quantinova.ai

872 : Targeting the UPR-Transcription Factor XBP1 to Overcome Drug-Resistance in Ph+ ALL

Researchers

Presenter

  • Christian Hurtz

Principal Investigators

  • Huimin Geng

  • Parham Ramezani-Rad

  • Laurie H. Glimcher

  • Suzanne Weiss Dean

  • Markus Muschen

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Multiple Myeloma

Biomarkers

  • p53

  • c-Jun N-terminal kinase

  • DNA Damage Inducible Transcript 3

  • Interleukin-7

  • X-Box Binding Protein 1

Drug/Treatment

  • Tamoxifen

  • Inositol

  • Afimoxifene

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved